Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Peptidomimetics (Dihexa): investigated as a small-molecule HGF/c-Met pathway modulator designed to cross the blood-brain barrier
Phase 2 trial results (48 weeks, adults with obesity): 1 mg dose: 7.2% body weight loss 4 mg dose: 12.9% body weight loss 8 mg dose: 17.3% body weight loss 12 mg dose: 24.2% body weight loss Placebo: 1.6% body weight loss Phase 3 TRIUMPH-4 results: 9 mg dose: 20.0% body weight loss (22.9 kg / 50.5 lbs) 12 mg dose: 23.7% body weight loss (27.2 kg / 60.0 lbs) Placebo: 4.6% body weight loss In a separate phase 3 analysis, retatrutide at the highest dose achieved up to 28.7% weight loss
Prices are display purpose only, pls DM us for final quotation
Research published in the Journal of Pharmaceutical Sciences demonstrated that mechanical agitation and high shear forces reduce bioactive peptide concentration by up to 30% even when other storage conditions are optimal
Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis
required for the transport of fatty acids through the inner mitochondrial membrane
US$ 28.73
US$ 22.65
US$ 21.30
US$ 29.66
US$ 24.49
US$ 21.69
US$ 27.69
US$ 25.00
US$ 26.82
US$ 26.24
US$ 29.49
